Primary plasma cell leukemia: A case report and review of the literature

Abstract

Abstract Due to the rarity and fulminant nature of the condition, there are limited data driving dialogue for optimal treatment strategies for plasma cell leukemia (PCL). Additionally, the current diagnostic definition of PCL has not been prospectively studied which may result in delays to initiating early aggressive treatment due to underdiagnosis.

Keywords

• daratumumab
• Kyle's criteria
• multiple myeloma
• plasma cell leukemia